Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 11 April 1986:
Vol. 232. no. 4747, pp. 220 - 223
DOI: 10.1126/science.3952505

Articles

Science, Vol 232, Issue 4747, 220-223
Copyright © 1986 by American Association for the Advancement of Science


articles

Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees

RC Kennedy, JW Eichberg, RE Lanford, and GR Dreesman

Anti-idiotypic antibodies (anti-Id) that contain an internal image component that mimics the surface antigen of hepatitis B virus (HBsAg) were used to immunize chimpanzees. Four injections of the rabbit anti-Id preparation elicited an antibody response to HBsAg (anti-HBs). The antibody specificity appeared to be against the anti-Id, since the anti-Id immunogen was shown to bind the chimpanzee anti-HBs. Two chimpanzees immunized with the anti-Id, along with two control animals that were either untreated or received a nonimmune rabbit immunoglobulin G preparation, were challenged with infectious hepatitis B virus. Both control chimpanzees developed clinical and serological characteristics consistent with an active hepatitis B virus infection, whereas the two anti-Id treated chimpanzees were protected from infection. Since chimpanzees provide a relevant model of a human response to hepatitis B virus immunization and infection, these results indicate that anti-Id preparations such as that described here might be candidates for vaccines against human diseases.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Comparison and Characterization of Immunoglobulin G Subclasses among Primate Species.
M. H. Shearer, R. D. Dark, J. Chodosh, and R. C. Kennedy (1999)
Clin. Vaccine Immunol. 6, 953-958
   Abstract »    Full Text »    PDF »
Anti-idiotypic Antibodies as Vaccine Candidates: The Immune Network.
M. J. Rico and R. P. Hall III (1989)
Arch Dermatol 125, 271-275
   Abstract »    PDF »
Development and testing of AIDS vaccines.
W. Koff and D. Hoth (1988)
Science 241, 426-432
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)